Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid-19 entities : Dynavax technologies corporation save search
Valneva Provides Clinical and Regulatory Updates for its COVID-19 Vaccine VLA2001
Published: 2023-03-02 (Crawled : 08:00) - biospace.com/
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: -0.88%
H: 1.29%
C: 0.79%
covid-19 valneva vaccine vla2001
Clover Provides Updates on COVID-19 Vaccine Commercial Launch and Strategic Priorities in 2023
Published: 2023-01-16 (Crawled : 01:00) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
| Email alert
Add to watchlist
covid-19 clover vaccine commercial
Valneva Reports Further Heterologous Booster Data for its inactivated COVID-19 vaccine
Published: 2022-12-30 (Crawled : 18:00) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: -1.31%
H: 1.24%
C: 1.14%
covid-19 valneva vaccine
Clover’s COVID-19 Vaccine Candidate Receives European Union GMP Certificate
Published: 2022-09-20 (Crawled : 09:00) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: -1.69%
H: 3.4%
C: -0.77%
covid-19 candidate vaccine
Clover’s Universal COVID-19 Booster Vaccine Candidate Demonstrates Superior Neutralization of Omicron BA.5 Compared to Inactivated Vaccine
Published: 2022-09-19 (Crawled : 00:00) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: -1.69%
H: 3.4%
C: -0.77%
covid-19 candidate vaccine universal
Valneva and IDT Biologika Agree on Termination of their COVID-19 Collaboration
Published: 2022-09-16 (Crawled : 21:00) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
| Email alert
Add to watchlist
IDT | $36.59 -1.03% 0.0% 41K
|
Communications
| Email alert
Add to watchlist
covid-19 valneva collaboration
Valneva Announces Publication of its COVID-19 Vaccine Phase 3 Data in The Lancet Infectious Diseases
Published: 2022-09-06 (Crawled : 07:00) - biospace.com/
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: 1.61%
H: 0.0%
C: -5.62%
covid-19 valneva vaccine lancet publication
Clover’s COVID-19 Vaccine Candidate Demonstrates Superior Booster Responses Compared to Inactivated Vaccine
Published: 2022-09-05 (Crawled : 00:00) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: 1.61%
H: 0.0%
C: -5.62%
covid-19 candidate vaccine
Clover’s COVID-19 Booster Vaccine Candidate Demonstrates Robust Neutralization of Dominant Omicron BA.5
Published: 2022-08-29 (Crawled : 00:00) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: 1.64%
H: 1.7%
C: 1.43%
covid-19 candidate vaccine
Clover Announces Positive Phase 2/3 Results in Adolescents for its COVID-19 Vaccine
Published: 2022-08-25 (Crawled : 11:00) - biospace.com/
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: 1.29%
H: 2.72%
C: -1.11%
covid-19 clover vaccine positive phase 2
Valneva Confirms WHO Recommendations for its Inactivated COVID-19 Vaccine
Published: 2022-08-23 (Crawled : 16:00) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: 0.43%
H: 1.19%
C: -0.42%
covid-19 valneva vaccine
Valneva Confirms Amendment of Advance Purchase Agreement with European Commission for Valneva’s Inactivated COVID-19 Vaccine
Published: 2022-08-01 (Crawled : 16:00) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: -0.07%
H: 0.84%
C: -2.3%
covid-19 valneva vaccine agreement
European Commission Approves Purchase Agreement Amendment for Valneva’s Inactivated COVID-19 Vaccine
Published: 2022-07-20 (Crawled : 20:00) - biospace.com/
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: 0.41%
H: 6.09%
C: 3.7%
covid-19 vaccine agreement
Clover’s COVID-19 Vaccine Candidate Demonstrates Strong Cross-Neutralization Against Omicron as a Homologous Booster
Published: 2022-06-27 (Crawled : 12:00) - biospace.com/
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: -0.24%
H: 3.41%
C: 1.63%
covid-19 candidate vaccine
Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001
Published: 2022-06-24 (Crawled : 17:00) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: -0.65%
H: 1.52%
C: 1.07%
covid-19 valneva europe vaccine vla2001 authorization
Valneva Receives Positive CHMP Opinion for Marketing Authorization of its Inactivated COVID-19 Vaccine Candidate in Europe
Published: 2022-06-23 (Crawled : 13:20) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: 0.52%
H: 6.31%
C: 6.23%
covid-19 valneva europe candidate chmp vaccine authorization positive
Clover Doses First Participants in Phase 3 Trial Evaluating SCB-2019 as a Heterologous COVID-19 Booster Following Prior Vaccination with Inactivated, mRNA or Viral Vector Vaccines
Published: 2022-06-14 (Crawled : 01:00) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: -5.45%
H: 3.46%
C: 0.67%
scb-2019 covid-19 clover mrna trial phase 3 vaccine
Valneva Provides Update on European Inactivated, Whole-Virus COVID-19 Vaccine Program VLA2001
Published: 2022-06-10 (Crawled : 17:00) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: -3.08%
H: 0.0%
C: 0.0%
covid-19 valneva vaccine vla2001 program
EMA Accepts Filing of Marketing Authorization Application for Valneva’s Inactivated COVID-19 Vaccine Candidate
Published: 2022-05-19 (Crawled : 07:00) - biospace.com/
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: 1.38%
H: 17.99%
C: 16.95%
covid-19 vaccine ema application authorization
Valneva Receives Notice of European Commission’s Intent to Terminate COVID-19 Vaccine Purchase Agreement
Published: 2022-05-16 (Crawled : 06:00) - globenewswire.com
DVAX | $11.42 -2.89% -2.98% 1.3M
|
Health Technology
|
| O: 5.69%
H: 6.75%
C: 3.59%
covid-19 valneva vaccine
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.